Lincoln Pharmaceuticals appointed Pradeep Kumar Yadav as Senior General Manager, Quality Assurance, effective September 24, 2026. The appointment designates him as Senior Management Personnel under SEBI LODR regulations.

Yadav possesses over 20 years of experience in the pharmaceutical industry. His expertise includes Quality Management Systems, audit compliance, validation, and IPQA. He has managed international regulatory inspections by USFDA, MHRA, TGA, and WHO Geneva.

Appointment details

The company filed the intimation with the National Stock Exchange and BSE Limited on September 24, 2026. The appointment is effective immediately with no specified term limit. Yadav will be based at the manufacturing facility in Khatraj, Gujarat.

Regulatory compliance

The disclosure was made pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Trusha Kashish Shah, Company Secretary and Compliance Officer, signed the digital filing.

The appointment letter outlines a six-month probation period. It also specifies a two-year bond commitment, requiring a cheque equivalent to two months of CTC to secure training and infrastructure resources.

Lincoln Pharmaceuticals Ltd has accepted the resignation of Manoj Rai, Senior General Manager and Head of Quality Assurance (QA), with effect from September 24, 2026. Rai cited personal reasons for his departure from the senior management role.

The company informed stock exchanges in a regulatory filing that Rai’s resignation is effective after close of business hours on the specified date. The move was disclosed under Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resignation details

According to the filing, Rai submitted his resignation letter on June 13, 2026. In the letter, he stated his decision to pursue a new professional opportunity aligned with his long-term career aspirations. He expressed gratitude to the management and leadership team for the support extended during his tenure.

Rai indicated his readiness to serve the prescribed three-month notice period. However, he requested early relief by adjusting his available earned or privilege leave balance against a portion of the notice period, subject to organizational approval and requirements.

Regulatory disclosure

The company provided the required details under SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The following table summarizes the key particulars disclosed:

The filing noted that the copy of the resignation letter was enclosed with the intimation. Trusha Kashish Shah, Company Secretary and Compliance Officer, signed the document digitally on September 24, 2026.